Epidemiology of tuberculosis in Minas Gerais, Brazil, between 2013 and 2023 and the impact of the COVID-19 pandemic
Frontiers in Public Health · 2025
DOI: 10.3389/fpubh.2025.1642015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Public Health, 2025. Verfasst von Renan Clímaco do Bem Braga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Brazil. Hauptthemen laut MEDLINE: COVID-19, Tuberculosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Tuberculosis (TB), a disease caused by bacteria of the Mycobacterium tuberculosis complex (MTC), is one of the oldest diseases in human history, and despite several global efforts to reduce case numbers, it remains one of the main causes of death worldwide due infectious agents. This study aimed to analyze the epidemiological trends of tuberculosis in Minas Gerais, Brazil, from 2013 to 2023, with emphasis on the impact of the COVID-19 pandemic on case notification.
Methods
Based on epidemiological data obtained from the DATASUS platform, spanning the period from 2013 to 2023, the number of cases, the distribution of confirmed cases by sex, race, education, age group, HIV co-infection and presence of comorbidities such as diabetes, and risk factors like smoking and alcoholism were evaluated. Additionally, the municipalities with the highest number of confirmed cases were identified.
Results
The research revealed a steady annual rise in TB cases, having the highest number of cases in 2023, with 12.55% of all reported cases. Men between 25 and 54 years of age, with a lower educational level, were the most affected by the disease. Regarding race, the majority of the reported cases were attributed to Brown-skinned people. The co-infection rate involving TB and HIV increased proportionally to the reported cases of TB statewide. Regarding comorbidities and risk factors, diabetes, smoking, and alcoholism composed a large part of the tuberculosis caseload, with alcoholism and smoking being especially related to the male population.
Conclusion
The results reinforced the gravity of tuberculosis as a public health challenge, while highlighting the impact of the COVID-19 pandemic on underreporting and the subsequent increase in reported cases of drug resistance involving tuberculosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Brazil.
- Teaching and Research Management, University Hospital of the Federal University of Juiz de Fora/Brazilian Company of Hospital Services, Juiz de Fora, Brazil.
- Department of Biological Sciences, Santa Cruz State University, Ilhéus, Brazil.
- Department of Clinical Medicine, Faculty of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Brazil.
- Department of Health, Santa Cruz State University, Ilhéus, Brazil.
Zitieren
APA
do Bem Braga, R. C., Meurer, I. R., D'Carmo Sodré, M. M., de Carvalho, L. D., Marin, L. J., Silvério, M. S., & Garcia, P. G. (2025). Epidemiology of tuberculosis in Minas Gerais, Brazil, between 2013 and 2023 and the impact of the COVID-19 pandemic. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1642015
Vancouver
do Bem Braga RC, Meurer IR, D'Carmo Sodré MM, de Carvalho LD, Marin LJ, Silvério MS, et al. Epidemiology of tuberculosis in Minas Gerais, Brazil, between 2013 and 2023 and the impact of the COVID-19 pandemic. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1642015
BibTeX
@article{doBemBraga2025,
author = {do Bem Braga, Renan Clímaco and Meurer, Igor Rosa and D'Carmo Sodré, Maisah Meyhr and de Carvalho, Luciana Debortoli and Marin, Lauro Juliano and Silvério, Marcelo Silva and Garcia, Patrícia Guedes},
title = {Epidemiology of tuberculosis in Minas Gerais, Brazil, between 2013 and 2023 and the impact of the COVID-19 pandemic},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1642015}
}
EUVIMED